Found 6 matching trials
An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
PHASE1GSK239512 is being developed for the treatment of symptoms of cognitive imp...
Location
GSK Investigational Site
GSK239512 DDI Study
PHASE1The study will determine the effect of 400 mg once daily of ketoconazole at...
Location
GSK Investigational Site
Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
PHASE2This is a randomized, parallel group, placebo-controlled study designed to ...
Location
GSK Investigational Site
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
PHASE2This study aims to evaluate the cognitive enhancing effects and tolerabilit...
Location
GSK Investigational Site
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
PHASE2This study aims to evaluate the cognitive enhancing effects and tolerabilit...
Location
GSK Investigational Site
Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
PHASE1This is a safety and tolerability study to investigate the effect of GSK239...
Location
GSK Investigational Site